Clinical Trial Update: Oblimersen Sodium & Combination Chemotherapy in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 study evaluating oblimersen sodium in combination with chemotherapy for newly diagnosed diffuse large B-cell lymphoma has been terminated with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• oblimersen sodium (oblimersen sodium)

Snippet

Sponsor: University of Nebraska | Conditions: Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma | EARLY_Phase 1 | Status: TERMINATED | Results posted: 2018-08-31